The tremendous growth of viral vector-based applications, especially in the vaccine and gene therapy production areas, is forcing researchers to decide how best to scale their manufacturing processes accordingly. Ideally, scientists will be able to use the same system throughout their entire development process, from research and development to clinical and commercial manufacturing, in order to minimize variation and maximize efficiency.
Download this application note to learn more about scalable manufacturing strategies for lentiviral production.
